You searched for "ROP"
Diagnostic error rates for ROP detection by trainee ophthalmologists
The purpose of this study was to characterise common errors in ROP diagnosis by ophthalmologists-in-training in the USA and Canada. Case acquisition was from a web-based system used for ROP assessment from which 20 cases were selected. Fifty-five trainees from...
Prevalence and risk factors for ROP in Saudi Arabia
This study aimed to establish the prevalence of retinopathy of prematurity (ROP) among high-risk neonates in a tertiary centre, identify the most commonly associated risk factors and highlight the benefits of early treatment of type 2 ROP and ROP milder...
Risks for ROP development in mid and late preterm infants
The authors evaluated the incidence, risk factors and retinopathy of prematurity (ROP) development in mid and late preterm infants born at 32 to <37 weeks of gestational age (GA). This was a retrospective study of 5477 infants: 54.4% male. Overall,...
Postnatal weight gain as adjunct to ROP screening
The purpose of this study was to assess postnatal weight gain as a tool to stratify infants at risk of developing severe retinopathy of prematurity (ROP) in a US Midwestern neonatal ICU cohort. The authors sought to develop a simpler...
Risks of advanced ROP development in unscreened babies
The authors report a retrospective study of the prevalence of infants with stage 4b and 5 retinopathy of prematurity (ROP) who were never screened and the importance of screening guidelines. The study was conducted in a tertiary eye hospital in...
Risk for systemic hypertension in ROP with IVB or laser therapy
The purpose of this study was to investigate whether there is an association between intravenous bevacizumab (IVB) and hypertension among infants with severe retinopathy of prematurity (ROP) and comparing those treated with IVB to those treated with laser, or infants...
ROP ocular outcomes after Bevacizumab treatment
The relationship between refractive outcomes and biometric parameters were evaluated following intravitreal Bevacizumab (IVB) monotherapy. Sixty-three infants were grouped into 1) infants treated with VB monotherapy for ROP (six with zone 1 and eight with posterior zone II retinopathy of...
ROP incidence and treatment profile over time
The primary aims of this study were to report the incidence of severe ROP and its treatment in infants <27 and 30 weeks gestational age. Secondary aims were to compare this data with three previously reported cohorts: 2003-2005; 200/2550 with...
Pain score assessment in babies undergoing treatment for ROP
The aim of this study was to assess neonatal pain scores during laser treatment for retinopathy of prematurity (ROP) under sub-tenon anaesthetic with oral or rectal sedation. Sixty-two babies were included who have had ROP laser treatment over a seven...
Laser photocoagulation vs. intravitreal (IVT) aflibercept for ROP
The efficacy, recurrence rate and requirement for additional treatment were compared between laser photocoagulation and IVT of 1mg/0.025ml aflibercept in the treatment of retinopathy of prematurity (ROP). The study included 27 babies (51 eyes) who completed a follow-up period after...The ROP Network: a south-south collaboration to improve care for premature babies
Retinopathy of prematurity (ROP) is a disorder of the immature preterm retina and a leading cause of preventable, irreversible blindness in children. There are 15 million preterm births annually, and over 32,000 neonates became blind from ROP in 2010 [1]....
